Replies to post #77 on Amylyx Pharmaceuticals Inc (AMLX)

[Whalatane]

Ernie. re ICU

DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has successfully reached the halfway point in the NEUTRALIZE-AKI pivotal clinical trial, enabling a per protocol prespecified interim analysis by the trial’s independent Data Safety Monitoring Review Board (DSMB)
. SeaStar Medical anticipates the DSMB will report its findings to the company in the third quarter of 2025

Biggest market will be the adult population ...and that may be several yrs away even if this interim analysis is really positive .
JMO
Good luck
Kiwi